Clinical Trial Details
EORTC-62962
Back to Clinical Trials Database
Phase II Study of Caelyx (Doxorubicin HCl, pegylated liposomal) or Doxorubicin in previously untreated adult patients with advanced and/or metastatic soft tissue sarcomas.
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 06-May-1997 Date Step1 close: 30-Jun-1998 |
Data management at EORTC | Yes |
Design |
Phase 2 Randomized open label |
Targeted Sample size | EORTC Groups: 80 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/ |
NCT number |